Vladimir Gurevich founded Fugent LLC in 1996 in order to inspire healing discoveries. His vision was to enable the world’s pioneering researchers to “See the Unseen®” with gentle, reliable, and efficient products that could be made with minimal environmental impact.
Vladimir’s first innovation, FuGENE®6 was one of the first transfection reagent to be sold by Roche, BM and Promega, and is still an industry leader for transfecting DNA into eukaryotic cells. Later, Vladimir discovered the first non-liposomal 100% synthetic DNA transfection reagent, FuGENE®HD. This product is being used today in various biotech processes from the gentle interrogation of cellular action to the production of vaccines and medicines.
The FuGENE® vision is to inspire healing discoveries and empower our customers to solve some of the world’s most challenging problems. By understanding the challenges facing scientists at the forefront of discovery, FuGENE® is working to identify and empower best-in-class solutions for our customers.
For over 25 years FuGENE® has been striving to find these solutions by developing products that are gentle, reliable, and effective, so the world’s pioneering scientists have the best products possible to See the Unseen®. From our first peer-reviewed publication in 1998, to our now thousands of peer reviewed publications, we are here to make a true difference for our customers and their groundbreaking research.